» Articles » PMID: 38339087

Beneficial Impact of Eicosapentaenoic Acid on the Adverse Effects Induced by Palmitate and Hyperglycemia on Healthy Rat Chondrocyte

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Feb 10
PMID 38339087
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is the most prevalent form of arthritis and a major cause of pain and disability. The pathology of OA involves the whole joint in an inflammatory and degenerative process, especially in articular cartilage. OA may be divided into distinguishable phenotypes including one associated with the metabolic syndrome (MetS) of which dyslipidemia and hyperglycemia have been individually linked to OA. Since their combined role in OA pathogenesis remains to be elucidated, we investigated the chondrocyte response to these metabolic stresses, and determined whether a n-3 polyunsaturated fatty acid (PUFA), i.e., eicosapentaenoic acid (EPA), may preserve chondrocyte functions. Rat chondrocytes were cultured with palmitic acid (PA) and/or EPA in normal or high glucose conditions. The expression of genes encoding proteins found in cartilage matrix (type 2 collagen and aggrecan) or involved in degenerative (metalloproteinases, MMPs) or in inflammatory (cyclooxygenase-2, COX-2 and microsomal prostaglandin E synthase, mPGES) processes was analyzed by qPCR. Prostaglandin E (PGE) release was also evaluated by an enzyme-linked immunosorbent assay. Our data indicated that PA dose-dependently up-regulated the mRNA expression of and . PA also induced the expression of and and promoted the synthesis of PGE. Glucose at high concentrations further increased the chondrocyte response to PA. Interestingly, EPA suppressed the inflammatory effects of PA and glucose, and strongly reduced MMP-13 expression. Among the free fatty acid receptors (FFARs), FFAR4 partly mediated the EPA effects and the activation of FFAR1 markedly reduced the inflammatory effects of PA in high glucose conditions. Our findings demonstrate that dyslipidemia associated with hyperglycemia may contribute to OA pathogenesis and explains why an excess of saturated fatty acids and a low level in n-3 PUFAs may disrupt cartilage homeostasis.

References
1.
Sekar S, Shafie S, Prasadam I, Crawford R, Panchal S, Brown L . Saturated fatty acids induce development of both metabolic syndrome and osteoarthritis in rats. Sci Rep. 2017; 7:46457. PMC: 5394476. DOI: 10.1038/srep46457. View

2.
Frommer K, Schaffler A, Rehart S, Lehr A, Muller-Ladner U, Neumann E . Free fatty acids: potential proinflammatory mediators in rheumatic diseases. Ann Rheum Dis. 2013; 74(1):303-10. DOI: 10.1136/annrheumdis-2013-203755. View

3.
Wu C, Jain D, McNeill J, Little D, Anderson J, Huebner J . Dietary fatty acid content regulates wound repair and the pathogenesis of osteoarthritis following joint injury. Ann Rheum Dis. 2014; 74(11):2076-83. PMC: 4363043. DOI: 10.1136/annrheumdis-2014-205601. View

4.
Chen Y, Chan D, Lan K, Wang C, Chen C, Chao S . PPARγ is involved in the hyperglycemia-induced inflammatory responses and collagen degradation in human chondrocytes and diabetic mouse cartilages. J Orthop Res. 2014; 33(3):373-81. DOI: 10.1002/jor.22770. View

5.
Frey M, Barrett-Connor E, Sledge P, Schneider D, Weisman M . The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol. 1996; 23(4):716-22. View